Company news
Avenir Wellness Solutions Inc. (OTC:AVRW) news
Avenir Wellness Solutions Inc. news releases on 6ix. Latest, May 18, 2017: CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary…
Press releases — page 4
CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary CureFilm™ Drug Delivery Technology
May 18, 2017
CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry
May 10, 2017
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
May 9, 2017
CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors
May 3, 2017
CURE Pharmaceutical Announces Development and Licensing Deal with Redbarn Pet Products
March 29, 2017
CURE Pharmaceutical To Exhibit at the 8th Global Drug Delivery & Formulation Summit
March 27, 2017
CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board
March 23, 2017
CURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.
March 21, 2017
CURE Pharmaceutical To Exhibit at INTERPHEX 2017 in New York City
March 16, 2017
Industry Veteran Jessica Rousset Joins CURE Pharmaceutical As Chief Business Officer
March 15, 2017
CURE Pharmaceutical Announces US Patent Allowances for Its Oral Thin Film Technology For Manufacture and Use in Pet Products
March 13, 2017
CURE Pharmaceutical Announces Research Collaboration with CannaKids to Develop Cannabinoid and Terpene Molecules Using Cure’s Proprietary Delivery Technologies
March 6, 2017
CURE Pharmaceutical Welcomes Industry Veteran Richard Serbin to its Advisory Board
January 27, 2017
CURE Pharmaceutical Moves to OTCQB Exchange
January 24, 2017
OTC Markets Group Welcomes Newly Verified OTCQB Companies – January 24
January 24, 2017